Literature DB >> 3008998

Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship.

D Fabbro, W Küng, W Roos, R Regazzi, U Eppenberger.   

Abstract

Quantitative polyacrylamide gel electrophoresis analysis of Ca2+, phospholipid-dependent protein kinase (PKC) of human mammary tumor cell lines (MCF-7, ZR-75, T-47-D, MDA-MB-231, BT-20, and HBL-100) revealed that 80% of the total cellular PKC resided in the cytosol. The tumor cells with no detectable levels of estrogen receptors (MDA-MB-231, HBL-100, and BT-20 cells) exhibited significantly larger (P less than 0.001) cytosolic PKC activities than those cells that contained estrogen receptors (MCF-7, T-47-D, and ZR-75 cells). In addition, in estrogen receptor-negative cell lines, relatively high levels of specific low-affinity (apparent Kd = 700 pM) epidermal growth factor (EGF) binding activities were found as compared with estrogen receptor-positive cells with significantly (P less than 0.001) lower levels of specific high-affinity (apparent Kd = 90 pM) EGT binding. A significant positive correlation (P less than 0.01) was observed between the number of EGF receptor (Rs = 0.50) and/or the EGF receptor dissociation constants (Rs = 0.78) with the cytosolic PKC activity levels. These data indicate that, in human breast cancer cells, a positive relationship may exist between PKC activity, estrogen, and EGF receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008998

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Characterization of epidermal growth factor receptors on plasma membranes isolated from rat gastric mucosa.

Authors:  R Hori; H Nomura; S Iwakawa; K Okumura
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

2.  Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases.

Authors:  J D Jacquemier; J Hassoun; M Torrente; P M Martin
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

3.  Regulation of ribosomal protein S6 kinase in human mammary tumor cells: effect of estrogen, growth factors and phorbol ester.

Authors:  I Novak-Hofer; W Küng; D Fabbro; A Matter; U Eppenberger
Journal:  Experientia       Date:  1988-02-15

4.  Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer.

Authors:  J W Assender; J M W Gee; I Lewis; I O Ellis; J F R Robertson; R I Nicholson
Journal:  J Clin Pathol       Date:  2007-11       Impact factor: 3.411

5.  17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells.

Authors:  Youko Fukata; Xiao Yu; Hitomi Imachi; Takamasa Nishiuchi; Jingya Lyu; Kayoko Seo; Akihiro Takeuchi; Hisakazu Iwama; Hisashi Masugata; Hiroshi Hoshikawa; Naohisa Hosomi; Yasumasa Iwasaki; Koji Murao
Journal:  Endocrine       Date:  2013-12-18       Impact factor: 3.633

Review 6.  Biology of the protein kinase C family.

Authors:  C A O'Brian; N E Ward
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

7.  Phorbol-12-myristate 13-acetate acting through protein kinase Cepsilon induces translocator protein (18-kDa) TSPO gene expression.

Authors:  Amani Batarseh; Christoforos Giatzakis; Vassilios Papadopoulos
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

8.  Epidermal growth factor receptor in human breast cancers: correlation with estrogen and progesterone receptors.

Authors:  J C Delarue; S Friedman; H Mouriesse; F May-Levin; H Sancho-Garnier; G Contesso
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

9.  Downregulation of RhoGDIα increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells.

Authors:  Somayeh Hooshmand; Abbas Ghaderi; Khatijah Yusoff; Thilakavathy Karrupiah; Rozita Rosli; Zahra Mojtahedi
Journal:  Cell Adh Migr       Date:  2013-04-05       Impact factor: 3.405

10.  Different Expression of Extracellular Signal-Regulated Kinases (ERK) 1/2 and Phospho-Erk Proteins in MBA-MB-231 and MCF-7 Cells after Chemotherapy with Doxorubicin or Docetaxel.

Authors:  Aliakbar Taherian; Tahereh Mazoochi
Journal:  Iran J Basic Med Sci       Date:  2012-01       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.